- Home
- ABOS vs DAVA Comparison
ABOS vs DAVA Comparison
Compare ABOS & DAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABOS | DAVA |
|---|---|---|
| Founded | 1996 | 2000 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 197.9M | 159.1M |
| IPO Year | 2021 | 2015 |
Fundamental Metrics
Financial Performance| Metric | ABOS | DAVA |
|---|---|---|
| Price | $2.87 | $2.95 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 9 |
| Target Price | $8.00 | ★ $13.50 |
| AVG Volume (30 Days) | ★ 342.1K | 185.3K |
| Earning Date | 05-12-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.07 |
| P/E Ratio | ★ N/A | $20.02 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.21 | $2.55 |
| 52 Week High | $3.60 | $9.97 |
Technical Indicators
Market Signals| Indicator | ABOS | DAVA |
|---|---|---|
| Relative Strength Index (RSI) | 51.98 | 48.28 |
| Support Level | $2.13 | $2.67 |
| Resistance Level | $3.02 | $3.03 |
| Average True Range (ATR) | 0.19 | 0.13 |
| MACD | -0.04 | -0.03 |
| Stochastic Oscillator | 33.33 | 36.51 |
Price Performance
Historical ComparisonAbout ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.
About DAVA Endava plc (each representing one)
Endava is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2006 in the UK, and it continues to generate the majority of revenue in the UK and Europe. Endava's client base is concentrated in the payments and financial services, technology, media, and telecom industries.